Latest Asx Price Query News

BPH Energy has responded to ASX inquiries about unusual trading activity, confirming no undisclosed information and highlighting ongoing Federal Court proceedings related to the PEP 11 project.

333D Limited has had its trading suspension lifted following a capital raise announcement and response to an ASX price query, signaling renewed market activity.

Terra Metals Limited has responded to an ASX price query following a sharp rise in its share price, confirming no undisclosed information is driving the movement and highlighting the start of Phase 3 drilling at its Dante Project.

Latitude 66 Limited has responded to an ASX price query concerning unusual trading activity, confirming no undisclosed material information exists and referencing prior announcements about a joint venture sale and recent assay results.

Rubix Resources (ASX, RB6) has resumed trading after lifting its suspension, following key announcements on its drilling program, capital raising, and a proposed acquisition.

Rubix Resources Limited has responded to ASX inquiries about unusual trading activity by disclosing initial drilling observations at its Paperbark Project and preliminary discussions on a potential acquisition, while cancelling a planned capital raising.

Dotz Nano has responded to an ASX price query following unusual trading activity, confirming no undisclosed information and reaffirming compliance with continuous disclosure rules.

Yandal Resources has clarified that a recent spike in its share price follows a significant off-market block trade, with no undisclosed material information influencing the market. The company also signals imminent drilling activity at its Ironstone Well-Barwidgee Gold Project.

Kaili Resources has responded to an ASX price query following a dramatic rise in its share price, denying any undisclosed material information and confirming full compliance with ASX listing rules.

Kaili Resources has officially confirmed a change of control with Mr Jianzhong Yang now holding over 60% of shares, alongside a significant board reshuffle. The company remains focused on advancing its rare earth elements exploration in South Australia.

Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.

Weebit Nano has responded to an ASX price query following a sharp rise in its share price and trading volume, attributing the activity to a misleading article on the Motley Fool website. The company denies any undisclosed price-sensitive information and confirms full compliance with ASX disclosure rules.